Sign up to receive our coronavirus (COVID-19) alerts and save the link to our resource page for guidance on a multitude of issues, including data privacy concerns, supply chain disruption, immigration status requirements, remote work opportunities and challenges, commercial relationship disruption, and ongoing federal and state updates, among many others.
Up & Atom
KEY TRENDS IN LAW AND POLICY REGARDING
NUCLEAR ENERGY AND MATERIALS
NUCLEAR ENERGY AND MATERIALS
The US House of Representatives Energy Subcommittee within the Committee on Science, Space, and Technology unanimously approved H.R. 6097 (Nuclear Energy Research and Development Act) on March 12. Representatives Dan Newhouse (R-WA) and Conor Lamb (D-PA) jointly introduced the bill.
The US Nuclear Regulatory Commission (NRC) Office of Investigations (OI) recently published its Office of Investigations Annual Report FY 2019, providing an overview of OI’s activities during the previous fiscal year. The report shows that OI opened 21% fewer cases in 2019 than in 2018, continuing the downward trend of the last 10 years.
In SECY 20-0020, issued on February 28, the NRC Staff informed the Commission of its conclusion that developing a generic environmental impact statement (GEIS) for advanced nuclear reactors (ANRs) is viable.
The director of the Nuclear Regulatory Commission’s (NRC) Office of Enforcement (OE) issued Enforcement Guidance Memorandum (EGM) 2020-001, “Enforcement Discretion Not to Cite Certain Violations of 10 CFR 73.56 Requirements” on February 13.
Check out our new resource, Responding to the 2019 Novel Coronavirus, to help guide your company through this new health crisis.
The US House of Representatives Committee on Science, Space, and Technology is requesting feedback on the proposed Nuclear Energy Research and Development Act by Wednesday, February 19. The Committee hopes to introduce the bill by the end of the month.
On February 5, DOE released a Request for Information/Notice of Intent (RFI/NOI), which announced DOE’s intent to solicit applications for two Advanced Reactor Demonstration (ARD) awards. Each award will be in the amount of $80 million for the first year, with additional funding dependent on individual project requirements and congressional appropriations. The projects are expected to be operational within five to seven years of the award.
The NRC’s Reactor Decommissioning Financial Assurance Working Group recently held a public meeting to receive comments on potential guidance updates before publishing its final report. Prior to the public meeting, the working group shared a presentation summarizing its findings and proposals.
The NRC’s Office of Nuclear Reactor Regulation and Office of Nuclear Material Safety and Safety and Safeguards recently issued two Information Notices (INs) in response to medical events arising from the administration of radiopharmaceuticals.